Conflict of Interest (COI)
ASCO regards the management of potential conflicts of interest as paramount to the integrity of ASCO’s programs, products and services. As a continuing education provider accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), and an original signatory to the Council of Medical Specialty Societies’ Code for Interactions with Companies, ASCO strives for independence, objectivity, transparency, and scientific rigor in all its activities through appropriate disclosure and management of financial relationships, among other things. The ASCO Policy for Relationships with Companies (COI Policy) was developed to help guide the management of potential conflicts, primarily through disclosure of all financial relationships that might result in actual, potential, or perceived conflicts of interest. ASCO’s COI Policy was first published in 1994 and was subsequently updated in July 1996, November 2002, March 2005, April 2013, and January 2017.
ASCO requires participants in its activities—and all Board of Directors and committee members—to disclose all of their financial relationships with for-profit health care companies. ASCO’s Policy is not intended to create a presumption of impropriety based on the existence of financial relationships with companies, rather the goal is to achieve full transparency through the disclosure of those relationships. Although the ASCO Policy relies primarily on disclosure of financial relationships, it also recognizes that some relationships cannot be managed with disclosure alone and identifies additional management steps in this case.